Vascular Allografts Market Report 2026

Vascular Allografts Market Overview

• Vascular Allografts market size has reached to $1.84 billion in 2025 • Expected to grow to $2.58 billion in 2030 at a compound annual growth rate (CAGR) of 7% • Growth Driver: Increasing Prevalence Of Cardiovascular Diseases Fueling The Growth Of The Market Due To Rising Incidence Of Heart And Vascular Disorders • Market Trend: Innovative Tissue-Engineered Vessels Offer New Hope For Urgent Arterial Revascularization • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Vascular Allografts Market?

Vascular allografts refer to blood vessels harvested from a human donor and transplanted into another patient to replace or bypass damaged or diseased vessels. These grafts are used to restore blood flow in cases where a patient’s own vessels are unsuitable for grafting, such as in bypass surgeries or vascular reconstruction. The main types of vascular allografts are cortical allograft, cancellous allograft, and corticocancellous allograft. Cortical allograft refers to a type of bone graft derived from the dense outer layer of donor bone, used to provide structural support and promote bone healing in orthopedic and dental procedures. The material used in these allografts encompasses biologic materials, synthetic materials, composite materials, and polymer-based materials, and these find applications in cardiovascular surgery, peripheral vascular surgery, transplant surgery, and repair of congenital defects. They are distributed through various channels such as direct sales, online sales, distributors, and medical supply stores, serving a diverse range of end users such as hospitals, ambulatory surgical centers (ASCs), specialty clinics, and research and academic institutions.

What Is The Vascular Allografts Market Growth Forecast?

The vascular allografts market size is expected to see strong growth in the next few years. It will grow to $2.58 billion in 2030 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to advancements in graft preservation and processing technologies, rising minimally invasive vascular procedures, growth in transplant surgeries, increasing use of composite and polymer-based materials, expansion of research and academic institutions in regenerative medicine. Major trends in the forecast period include rising demand for vascular allografts in cardiovascular surgeries, increased use of cortical and cancellous allografts, adoption of fresh frozen and freeze-dried grafts, expansion of peripheral vascular and transplant surgeries, focus on biologic and composite material innovations.

Global Vascular Allografts Market Segmentation

1) By Type: Cortical Allograft, Cancellous Allograft, Corticocancellous Allograft 2) By Material Type: Biologic Materials, Synthetic Materials, Composite Materials, Polymer-Based Materials 3) By Application: Cardiovascular Surgery, Peripheral Vascular Surgery, Transplant Surgery, Repair Of Congenital Defects 4) By Distribution Channel: Direct Sales, Online Sales, Distributors, Medical Supply Stores 5) By End-User: Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics, Research And Academic Institutions Subsegments: 1) By Cortical Allograft: Structural Cortical Allografts, Segmental Cortical Allografts, Shaped Cortical Allografts, Machined Cortical Allografts 2) By Cancellous Allograft: Granular Cancellous Allografts, Block Cancellous Allografts, Molded Cancellous Allografts, Injectable Cancellous Allografts 3) By Corticocancellous Allograft: Composite Corticocancellous Allografts, Block Corticocancellous Allografts, Shaped Corticocancellous Allografts, Structural Corticocancellous Allografts

What Is The Driver Of The Vascular Allografts Market?

The increasing prevalence of cardiovascular diseases is expected to propel the growth of the vascular allografts market going forward. Cardiovascular diseases refer to a group of disorders affecting the heart and blood vessels, including conditions such as coronary heart disease, heart failure, stroke, and hypertension. The increasing prevalence of cardiovascular diseases is primarily attributed to poor diet, as the excessive consumption of saturated fats, trans fats, added sugars, and sodium contributes to high blood pressure, obesity, and elevated cholesterol levels. Vascular allografts enhance cardiovascular disease treatment options by providing ready-to-use donor blood vessels, making them ideal for patients with damaged or diseased vessels. They improve surgical outcomes by restoring proper blood flow, reducing complications, and supporting long-term cardiovascular health. For instance, in December 2024, GOV.UK, a UK-based government agency, reported that in March 2024, nearly 2.24 million adults in England—about 4.4% of those aged 18 and over—had a GP-recorded diagnosis of CKD. This reflects an increase from 2.09 million cases the previous year. Therefore, the increasing prevalence of cardiovascular diseases is driving the growth of the vascular allografts industry.

Key Players In The Global Vascular Allografts Market

Major companies operating in the vascular allografts market are Medtronic plc, Boston Scientific Corporation, Terumo Corporation, W. L. Gore & Associates Inc., Dentsply Sirona Inc., Integra LifeSciences Holdings Corporation, MicroPort Scientific Corporation, Bioventus Inc., KLS Martin Group, MTF Biologics, MTF Biologics, ZimVie Inc., B. Braun Melsungen AG, Artivion Inc., MiMedx Group Inc., RTI Surgical Inc, LeMaitre Vascular Inc., LifeNet Health Inc., Xtant Medical Holdings Inc., Osteogenics Biomedical Inc.

Global Vascular Allografts Market Trends and Insights

Major companies operating in the vascular allografts market are focusing on developing advanced products, such as bioengineered graft materials, to enhance graft durability, biocompatibility, and integration with the host tissue. Bioengineered graft material refers to specially designed vascular grafts that are created using advanced biological and engineering techniques. For instance, in February 2025, Humacyte Inc., a US-based biotechnology company, launched Symvess, a bioengineered vascular graft specifically designed for adults needing urgent revascularization due to extremity arterial injuries when autologous vein grafts are not an option. Symvess is engineered to remodel into the patient’s own tissue over time, reducing the risk of rejection and improving long-term outcomes. This graft also minimizes the need for immunosuppressive drugs, offering a significant advantage in trauma and emergency surgical settings.

What Are Latest Mergers And Acquisitions In The Vascular Allografts Market?

In May 2025, MTF Biologics, a US-based nonprofit organization, partnered with Kolosis BIO LLC to launch innovative allograft products. This partnership aims to expand the availability of advanced allograft solutions, enhance surgical outcomes, and provide surgeons with high-quality, ready-to-use grafts for complex vascular and orthopedic procedures. Kolosis BIO LLC is a US-based orthobiologics company specializing in the development and commercialization of vascular allograft products.

Regional Outlook

North America was the largest region in the vascular allografts market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Vascular Allografts Market?

The vascular allografts market consists of sales of arterial allografts, venous allografts, cryopreserved vascular grafts, fresh vascular grafts, and decellularized vascular allografts. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.